04.10.2012 • News

ANI Pharma to List Through Takeover of BioSante

Unlisted ANI Pharmaceuticals Inca, a speciality and generic pharmaceutical company is listing through the purchase of BioSante Pharmaceuticals, another drugmaker, in an all-stock deal.

BioSante will issue stock to ANI shareholders giving ANI stockholders a 53% stake in the combined company.

The combined company will be renamed ANI Pharmaceuticals and be led by the ANI management team, with Arthur Przybyl serving as chief executive officer, the companies said in a joint statement.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.